Drug Target Review Antibodies ebook 2021
Posted: 17 June 2021 | Drug Target Review | No comments yet
Within this ebook, find articles on antibodies to combat SARS-CoV-2 and an evaluation of the various therapeutic forms they can take.
With antibodies becoming ever more prevalent in therapeutic applications, their development is of great importance. In this ebook, discover more about this class of biologic.
Dr Zhiqiang Ku explains why antibodies are critical in the fight against COVID-19 and how a new cocktail has been developed to neutralise SARS‑CoV-2. In another article, Aparajita Dubey highlights the broad benefits of these therapeutics and how progress in design is enhancing their effectiveness.
Included in this ebook:
Drug Target Review has just announced the launch of its NEW and EXCLUSIVE report examining the evolution of AI and informatics in drug discovery and development.
In this 63 page in-depth report, experts and researchers explore the key benefits of AI and informatics processes, reveal where the challenges lie for the implementation of AI and how they see the use of these technologies streamlining workflows in the future.
Also featured are exclusive interviews with leading scientists from AstraZeneca, Auransa, PolarisQB and Chalmers University of Technology.
- How to mix the best anti-SARS-CoV-2 cocktail
Dr Zhiqiang Ku, University of Texas Health Science Center at Houston - Better therapeutic antibodies by design
Aparajita Dubey, CRAMbridge
Related topics
Antibodies, Biologics, Biopharmaceuticals, Protein, Proteomics, Therapeutics
Related organisations
Sartorius, Thermo Fisher Scientific
